Melucci

Melucci v. Corcept Therapeutics Incorporated

Good Law
United States District Court, Northern District of CaliforniaOctober 7, 20193:19-cv-01372California3,851 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN JOSE DIVISION

NICHOLAS MELUCCI, Case No. 19-CV-01372-LHK

Plaintiff,

ORDER APPOINTING LEAD

PLAINTIFF AND LEAD COUNSEL

v. Re: Dkt. Nos. 15, 17, 24, 29, 32, 58 CORCEPT THERAPEUTICS INCORPORATED, et al., 16 Defendants.

This case is a putative securities class action brought against Defendant Corcept Therapeutics Incorporated (“Corcept”); its President and Chief Executive Officer, Joseph K. Belanoff; and its Chief Financial Officer, Charles Robb. Plaintiffs in this action consist of “persons and entities that purchased or otherwise acquired Corcept securities between August 2, 2017 and February 5, 2019, inclusive (the ‘Class Period’).” ECF No. 1 (“Compl.”) ¶ 1. Before the Court are four outstanding Motions for Appointment as Lead Plaintiff and Approval of Lead Counsel. I. BACKGROUND Corcept is a “pharmaceutical company that purports to develop medications to treat severe metabolic, oncologic, and psychiatric disorders by modulating the…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.